S&P 500
(-1.44%) 4 998.77 points
Dow Jones
(-1.71%) 37 804 points
Nasdaq
(-1.94%) 15 408 points
Oil
(-0.47%) $82.42
Gas
(-1.63%) $1.626
Gold
(-0.22%) $2 333.30
Silver
(-0.46%) $27.22
Platinum
(-0.83%) $908.20
USD/EUR
(-0.01%) $0.934
USD/NOK
(0.20%) $11.01
USD/GBP
(-0.10%) $0.802
USD/RUB
(-0.07%) $92.26

Realtime updates for Medivir AB (publ) [MVIR-B.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-04-25)

Expected move: +/- 0.00%

Last Updated15 May 2023 @ 11:29

1.12% SEK 7.22

Live Chart Being Loaded With Signals

Commentary (15 May 2023 @ 11:29):

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name...

Stats
Today's Volume 38 387.00
Average Volume 28 216.00
Market Cap 402.33M
EPS SEK0 ( 2024-02-13 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -5.31
ATR14 SEK0.368 (5.06%)

Volume Correlation

Long: 0.23 (neutral)
Short: 0.83 (strong)
Signal:(44.353) Same movement expected

Medivir AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medivir AB (publ) Correlation - Currency/Commodity

The country flag 0.72
( moderate )
The country flag 0.76
( moderate )
The country flag 0.00
( neutral )
The country flag 0.31
( neutral )
The country flag 0.26
( neutral )
The country flag -0.74
( moderate negative )

Medivir AB (publ) Financials

Annual 2022
Revenue: SEK4.41M
Gross Profit: SEK-64.67M (-1 467.11 %)
EPS: SEK-1.600
Q2 2023
Revenue: SEK2.00M
Gross Profit: SEK-19.20M (-960.00 %)
EPS: SEK-0.480
Q1 2023
Revenue: SEK400 000
Gross Profit: SEK-12.70M (-3 175.00 %)
EPS: SEK-0.330
Q4 2022
Revenue: SEK2.31M
Gross Profit: SEK-13.47M (-583.62 %)
EPS: SEK-0.310

Financial Reports:

No articles found.

Medivir AB (publ)

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators